People fully vaccinated against COVID-19 can now travel without needing to self-quarantine or a negative coronavirus test; study finds COVID-19 vaccines safe and effective for pregnant and breastfeeding women; HHS launches a mask design contest with a substantial cash prize.
As reported by Roll Call, the CDC updated its travel guidelines this past Friday, which will allow individuals fully vaccinated against COVID-19 to travel throughout the United States and abroad without needing to self-quarantine or a negative coronavirus test. The guidelines consider individuals fully vaccinated at least 2 weeks after their last recommended dose of the vaccine, and they state that travelers must also wear a mask in public spaces. The guidance provides no update for unvaccinated people, who will still need to get tested 1 to 3 days before domestic travel and again 3 to 5 days after travel.
According to a recent study by the The American Journal of Obstetrics and Gynecology, COVID-19 vaccines were found to be safe and effective for pregnant and breastfeeding women, as well as potentially providing protection for their babies. According to NPR, the study involved 131 participants whose blood samples were taken at the time of the first and second doses of the vaccine, and again after 6 weeks. Notably, the level of antibodies for participants in response to the vaccine were higher than those in participants who were sick with COVID-19 during pregnancy, with antibodies also found in umbilical cord blood and breast milk. Researchers likened the discovery to that of the flu vaccine, which also provides protection for babies in the first several months of life.
Seeking to develop the next generation of masks, HHS launched a competition titled “Mask Innovation Challenge: Building Tomorrow’s Mask,” in which the participant with the winning mask design will receive a $500,000 cash prize. Reported by The Hill, HHS said that although mask use has been encouraged worldwide, present mask designs cause issues such as contact dermatitis with prolonged wear and physical discomfort. Each submitted design will be judged by 4 criteria, including technological feasibility, innovation, whether it addresses existing mask barriers, and overall design, with the contest set to expire on April 21 at 5:00 pm Eastern time.
Dr Chakra Chaulagain: PFS Is the "Bare Minimum," but OS Is Ideal for Choosing Between MM Therapies
March 28th 2024Response rates are important when choosing between therapies to treat multiple myeloma (MM), but improvement overall survival (OS) is the ideal, said Chakra Chaulagain MD, FACP, hematologist/oncologist, Maroone Cancer Center of Cleveland Clinic Florida.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Alopecia Areata Impacts Patient Perception, Quality of Life
March 27th 2024Patients with alopecia areata (AA) often perceive their hair loss as more severe than dermatologists do, leading to increased emotional and social problems. This study highlights the importance of understanding patient perception for better treatment and improved quality of life.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More